miR-26a in β cells alleviated obesity-induced insulin resistance and hyperinsulinemia, and prevented hyperinsulinemia through targeting several critical regulators of insulin secretion and β cell proliferation [58]. The gene discussed is INS; the disease is Hyperinsulinemia.